Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	2718.88	-225.66	8.01
Graham Fair Price	-78.45	0.12	0.56
PEG	10345.23	0.45	< 0.005
Price/Book	11.60	29.81	26.72
Price/Cash Flow	1709.33	-189.18	10.46
Prices/Earnings	1714.17	-47.42	2.61
Price/Sales	732.34	376.23	45.20
Price/FCF	1709.33	-189.18	10.46
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-6.07	0.74	0.79
Operating Margin	-55.44	-2.00	4.49
ROA	-93.88	-0.04	0.64
ROE	2.56	-0.16	-93.85
ROIC	1.16	-0.06	-94.55
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.02	1.61	-98.65
Dividends QOQ	-1.00	-1.00	-0.03
EBIT QOQ	7.10	-1.05	-85.18
EPS QOQ	6.07	-1.05	-82.63
FCF QOQ	6.07	-1.05	-82.62
Revenue QOQ	0.14	-0.88	533.86
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	29.76	100.00
Days Sales Outstanding (DSO)	0.00	4906.82	100.00
Inventory Turnover	0.00	3.02	100.00
Debt/Capitalization	0.56	0.60	6.57
Quick Ratio	0.20	0.51	154.17
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	0.07	0.06	-13.10
Cash	0.04	0.01	-71.36
Capex	< 0.005	< 0.005	-15.38
Free Cash Flow	0.19	-0.01	-94.64
Revenue	0.04	< 0.005	-88.35
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	0.64	0.53	-17.58
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	0.23	-9.65	4084.25
Naive Interpretation	Member

06 - Financial Health · Bad

Rating